BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2021
View Archived Issues
A different path to specificity for Ras inhibitors
Read More
Crinetics opens phase III study of paltusotine to treat acromegaly
Read More
LIB Therapeutics initiates phase III studies of lerodalcibep in hypercholesterolemia
Read More
BioNTech and Regeneron evaluate the combination of BNT-111 and cemiplimab in melanoma
Read More
Anti-CD6 therapy suppresses autoimmunity and enhances cancer cell death
Read More
Characterization of HSK-16149, a selective ligand of VGCC alpha2delta subunit
Read More
Phase I trial of a vaccine targeting tumor-associated antigens PSA, MUC-1 and brachyury in mCRPC
Read More
Adrenaline release immobilizes immune cell responses
Read More
Gene variants linked to premenstrual dysphoric disorder
Read More
IL-12 immunoconjugate SON-1010 generally well tolerated in cynomolgus monkeys
Read More
FDA clears IND application for PF-614-MPAR opioid with overdose protection
Read More
Patient dosing begins in phase Ib/II study of CFI-400945 in leukemia
Read More
European Commission approves Orladeyo for the prevention of HAE attacks
Read More
New model of metabolic syndrome-induced CKD in mice
Read More
Janssen Pharmaceutica divulges CB1 and/or CB2 receptor agonists
Read More
Esteve Pharmaceuticals patents new analgesics
Read More
Monte Rosa Therapeutics discloses new protein cereblon modulators
Read More
Heptares Therapeutics presents EP4 receptor antagonists
Read More
U.S. researchers discover new CARs against cytomegalovirus
Read More
FDA approves Farxiga for chronic kidney disease
Read More
FDA approves Ferriprox to treat transfusional iron overload due to sickle cell disease
Read More
Researchers identify new markers of treatment response in alcohol use disorder
Read More
FDA issues complete response letter for tralokinumab in moderate to severe atopic dermatitis
Read More
Synairgen reports home cohort and combined analysis from phase II trial of SNG-001 in COVID-19
Read More
Repare initiates phase I trial of oral PKMYT1 inhibitor RP-6306
Read More